alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6430 Liquid medication dispenser. ( a ) *Identification.* A Liquid medication dispenser is a device intended for medical purposes that is used to issue a measured amount of liquid medication.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 880.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 38806, July 25, 2001]
SERVED : MARC H 8 , 201 1 U.S . DEPARTMEN T O FTRANSPORTATIO N i ' ARl'MEN T O F OFFIC E O FHEARING S : ' ^ •'''PORWIO N WASHINGTON , D C ,• •. ] OPERATION S IN TH E MATTE RO F M & RHELICOPTE R FA A DOCKE T NO . CPlOSOOO l 1 (Civi l Penalty Action ) FDM S NO . FAA-2010-12 n U:2 5

NOTIC E O FPREHEARIN G CONFERENC E A Prehearin g Telephon e Conferenc e i s schedule do n Marc h 25 , 2011 , a t 3:0 0 p.m. , Easter n Time . Al l partie s shoul db e prepare dt o discus s al l issue s an dfact s at issue . Eac h party shal l ensur e tha t

th e Judg e receives , n o late r tha n Marc h 17 , 2011 , acop y o f eac h documen t

tha t party ha s provide dt o th e othe r

party but not th e Judge . Pursuan t t o Sectio n 55 6 o f

th e Administrativ e Procedur e Act , 5 U.S.C . § 556(c)(8) , eac h party shal l b e represente db y someon e wh o ha s authorit y t o negotiat e concernin g resolutio n o f al l issue s i n controversy . S O ORDERED . Loimie70ft5de r Chie f Admini5tmiveJ.,ca^udg e Attachmen t

- Servic e Lis tFA A Docke t No . CPlOSOOO

l 1 (Civi l Penalt

y Action ) SERVIjipiiS t ORIGINAL'#iii)'COP Y Federa l Aviation Administratio n fjir ^ I ; 80 0 Independenc e Avenue , S.W . Washington , DC 2059 1 ;: ' : } ' Attention : Hearing Docke t Clerk , A<jC-^3i||v

- i =

; Wilbu r Wrigh t Building--Suit e itislO ' Michae l Selig , MD , FACC , CFI-H , Respondent' s Representativ e 2816OrefieldRoa d' > i ^ Allentown , P

A 1810 4 TEL : 610-360-395 3 FAX : Laur aPonto , Complainant' s Counsel Attorney , Enforcemen

t Division/AGC-30 0 Offic e of the Chief Counsel Federa l Aviatio n Administratio n 800 Independenc e Avenue , S.W . Washington , DC 2059 1 TEL : 202-267-986 3 FAX : 202-267-510 6 ' * ' " Th e Honorable Rormi

e A . Yoder , Chief Administrativ e La

w Judg e U.S . Departmen

t of Transportatio n Offic e o f Hearings , M-20 , Roo

mE l 2-320 120 0 New Jersey Avenue , S.E . Washington , DC 2059 0 TEL : 202-366-214 2 FAX : 202-366-753 6 '

' Servic e wa s b y U.S . Mail . Fo r servic e j n perso n Oft^yf^i^^ite

dcourier , us e th e followi % address : Federa l Aviatio n Administration

, 60 0 Independenc

e AvWiui^Ml

^ Wil ^ Wrigh t Building—Suit

e 2W1000 , Washington , D C 20591 ; Attention: Hearin

g Docl^ t Cl«1c,lMiCl^0 .
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.1350 Mica-based pearlescent pigments. ( a ) *Identity.* ( 1 ) The color additive is formed by depositing titanium and/or iron salts onto mica, followed by heating to produce one of the following combinations: Titanium dioxide on mica; iron oxide on mica; titanium dioxide and iron oxide on mica. Mica used to manufacture the color additive shall conform in identity to the requirements of § 73.1496(a)(1).
( 2 ) Color additive mixtures for drug use made with mica-based pearlescent pigments may contain only those diluents listed in this subpart as safe and suitable for use in color additive mixtures for coloring ingested drugs.
( b ) *Specifications.* Mica-based pearlescent pigments shall conform to the following specifications and shall be free from impurities other than those named to the extent that such other impurities may be avoided by good manufacturing practice: ( 1 ) Lead (as Pb), not more than 4 parts per million (ppm).
( 2 ) Arsenic (as As), not more than 3 ppm.
( 3 ) Mercury (as Hg), not more than 1 ppm.
( c ) *Uses and restrictions.* Mica-based pearlescent pigments may be safely used to color ingested drugs in amounts up to 3 percent, by weight, of the final drug product. The maximum amount of iron oxide to be used in producing said pigments is not to exceed 55 percent, by weight, in the finished pigment.
( d ) *Labeling.* The label of the color additive and of any mixture prepared therefrom intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification requirements of section 721(c) of the Federal Food, Drug, and Cosmetic Act.
[70 FR 42273, July 22, 2005. Redesignated at 72 FR 10357, Mar. 8, 2007]
Meeting with Retail Industry Leadership Association (RILA) to Discuss the Rodenticide Mitigation Decision

Tuesday October 19, 2010 11:30am-12:30pm

Attendees: Laura Parsons (EPA), Neil Anderson (EPA), Rusty Wasem (EPA), Adam Siegel (RILA), Liz Benson (RILA), Sarah Walczewski (RILA)

EPA provided a brief presentation on how the 2008 Rodenticide Mitigation Decision will affect retailers. RILA provided EPA feedback on how the Agency can provide feedback to their members (Retail Operators).
Editorial Note on Part 888
Editorial Note: Nomenclature changes to part 888 appear at 73 FR 35341, June 23, 2008.

§ 888.3730 Toe joint phalangeal (hemi-toe) polymer prosthesis. ( a ) *Identification.* A toe joint phalangeal (hemi-toe) polymer prosthesis is a device made of silicone elastomer intended to be implanted to replace the base of the proximal phalanx of the toe.
( b ) *Classification.* Class II.
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1285 Etiocholanolone test system. ( a ) *Identification.* An etiocholanolone test system is a device intended to measure etiocholanolone in serum and urine. Etiocholanolone is a metabolic product of the hormone testosterone and is excreted in the urine. Etiocholanolone measurements are used in the diagnosis and treatment of disorders of the testes and ovaries.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2306, Jan. 14, 2000]
Exhibit 13.1



CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350



In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2022 (the “Report”) by Siyata Mobile Inc. (the “Company”),
the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:



| | (1) | the Report fully complies with the requirements of Section
13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|Date: May 15, 2023 | /s/ Marc Seelenfreund
|------------------ | ---------------------
|                   | Marc Seelenfreund
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.3920 Wheelchair component. ( a ) *Identification.* A wheelchair component is a device intended for medical purposes that is generally sold as an integral part of a wheelchair, but may also be sold separately as a replacement part. Examples of wheelchair components are the following: Armrest, narrowing attachment, belt, extension brake, curb climber, cushion, antitip device, footrest, handrim, hill holder, leg rest, heel loops, and toe loops.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 890.9.
[48 FR 53047, Nov. 23, 1983, as amended at 59 FR 63014, Dec. 7, 1994; 66 FR 38817, July 25, 2001]
* Pursuant to 5 TH CIR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH CIR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED April 11, 2006 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-40983 Conference Calendar

RUBEN ROCHA, Petitioner-Appellant,

versus RUDY CHILDRESS, Warden, Respondent-Appellee.

-------------------- Appeal from the United States District Court for the Eastern District of Texas USDC No. 1:04-CV-668

-------------------- Before JONES, Chief Judge, and JOLLY and DAVIS, Circuit Judges.
PER CURIAM: * Ruben Rocha, federal prisoner # 18815-077, appeals the district court’s dismissal of his 28 U.S.C. § 2241 petition, wherein he challenged his conviction for using or carrying a firearm during commission of a crime of violence, in violation of 18 U.S.C. § 924(c). Rocha challenged his conviction based on Bailey v. United States , 516 U.S. 137 (1995). Rocha argues that his challenge to the firearms offense falls within the savings clause of 28 U.S.C. § 2255. “[T]heNo. 05-40983 -2- savings clause of § 2255 applies to a claim (i) that is based on a retroactively applicable Supreme Court decision which establishes that the petitioner may have been convicted of a nonexistent offense and (ii) that was foreclosed by circuit law at the time when the claim should have been raised in the petitioner’s trial, appeal, or first § 2255 motion.” Reyes-Requena v. United States , 243 F.3d 893, 904 (5th Cir. 2001). This court has already held that the evidence was sufficient to support Rocha’s conviction for carrying a firearm under § 924(c). See United States v. Rocha , 916 F.2d 219, 236-37 (5th Cir. 1990). We have also held that this prior holding precludes Rocha from seeking the application of the savings clause under § 2255. See United States v. Rocha , 2002 WL 31049460 at *1 (5th Cir. Sept. 3, 2002). Rocha has not shown that he meets the first prong of the Reyes-Requena test. See Reyes-Requena , 243 F.3d at 904. Accordingly, the district court’s judgment is AFFIRMED.
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3630 *Serratia* spp. serological reagents. ( a ) *Identification. Serratia* spp. serological reagents are devices that consist of antigens and antisera used in serological tests to identify *Serratia* spp. from cultured isolates. The identification aids in the diagnosis of disease caused by bacteria belonging to the genus *Serratia* and provides epidemiological information on these diseases. *Serratia* spp. are occasionally associated with gastroenteritis (food poisoning) and wound infections.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 54 FR 25047, June 12, 1989; 66 FR 38792, July 25, 2001]
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000854860
<NAME>                        Williams Controls Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars
       
<S>                                            <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              Sep-30-1997
<PERIOD-START>                                 Oct-01-1996
<PERIOD-END>                                   Mar-31-1997
<EXCHANGE-RATE>                                     1
<CASH>                                          2,747
<SECURITIES>                                        0 
<RECEIVABLES>                                  11,343
<ALLOWANCES>                                        0 
<INVENTORY>                                    16,577
<CURRENT-ASSETS>                               32,807
<PP&E>                                         25,564
<DEPRECIATION>                                  5,856
<TOTAL-ASSETS>                                 54,759
<CURRENT-LIABILITIES>                          30,404
<BONDS>                                             0
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                          179
<OTHER-SE>                                     17,981
<TOTAL-LIABILITY-AND-EQUITY>                   54,759
<SALES>                                        32,860
<TOTAL-REVENUES>                               32,860
<CGS>                                          25,652
<TOTAL-COSTS>                                   6,083 
<OTHER-EXPENSES>                                  179
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                              1,185
<INCOME-PRETAX>                                  (239)
<INCOME-TAX>                                      (90)
<INCOME-CONTINUING>                              (149)
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                     (118)
<EPS-PRIMARY>                                    (.01)
<EPS-DILUTED>                                    (.01)
        


</TABLE>
EXHIBIT 10.13

                 Letter of Debt Forgiveness to Grand Prix Sports


                                                                   April 2, 2003
Mr. Todd M. Pitcher
President/Director
Grand Prix Sports, Inc.
Suite 230
23332 Mill Creek Drive
Laguna Hills, CA 92653


Dear Mr. Pitcher,

Please accept this letter as my approval and authorization to forgive the amount
of $38,864 currently owed to me by Grand Prix Sports, Inc. (GPRX). This amount
represents the total principal and interest due as of December 31, 2002.

The note and entire corresponding debt shall be considered cancelled upon the
nominal payment to me of $100 with the further understanding that both parties
shall endeavor to continue to work together in the future for their mutual
benefit.

Sincerely,

/S/ Harrysen Mittler
-------------------------------------------------
Harrysen Mittler
# C_2018427EN.01003701.xml

| 26.11.2018 | EN | Official Journal of the European Union | C 427/37 |
| --- | --- | --- | --- |

26.11.2018

EN

Official Journal of the European Union

C 427/37

---

Judgment of the General Court of 26 September 2018 — EAEPC v Commission

(Case T-574/14) (1)

(Competition - Agreements, decisions and concerted practices - Parallel trade in medicines - Agreement operating a distinction between prices charged for products intended for resale in Spain and prices charged for products intended for export to other Member States - Request for re-examination of a complaint following judgments of the Court of Justice and the General Court - Article 266 TFEU - Rejection of a complaint - No Union interest - Cessation of the anti-competitive practice - Absence of persisting anti-competitive effects - Case being dealt with by a competition authority of a Member State - Obligations in relation to the investigation of a complaint - Article 105 TFEU - Article 7 of Regulation (EC) No 1/2003 - Procedural rights of a complainant - Obligation to state reasons)

(2018/C 427/45)

Language of the case: English

Parties

Applicant: European Association of Euro-Pharmaceutical Companies (EAEPC) (Brussels, Belgium) (represented by: J.L. Buendía Sierra, L. Ortiz Blanco, Á. Givaja Sanz and M. Araujo Boyd, lawyers)

Defendant: European Commission (represented by: F. Castilla Contreras, F. Jimeno Fernández and C. Vollrath, Agents)

Interveners in support of the defendant: GlaxoSmithKline plc (Brentford, United Kingdom) and GlaxoSmithKline SA (Madrid, Spain) (represented by: initially I.S. Forrester QC, and A. Komninos, lawyer, and subsequently A. Komninos)

Re:

Application under Article 263 TFEU for annulment of Commission Decision C(2014) 3654 final of 27 May 2014 rejecting the complaint filed by the applicant concerning an alleged infringement by Glaxo Wellcome SA of Article 101 TFEU (Case COMP/AT.36957 — Glaxo Wellcome).

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders each party to bear its own costs. |
| --- | --- |

2.

Orders each party to bear its own costs.

---

(1)  OJ C 409, 17.11.2014.

---
39271.

#### ALEXANDER v. GLOBE INDEMNITY COMPANY *et al.*

Decided January 16, 1962.

*Oze R. Horton,*for plaintiff in error.

*Greene, Neely, Buckley <& DeRieux, Burt DeRieux,*contra.

Eberhardt, Judge.

Under numerous decisions of this court, an award of the Workmen’s Compensation Board will not be disturbed where there is any evidence to support it. Here, there is *no*evidence to the contrary and the award is affirmed. *Judgment affirmed. Carlisle, P. J., and Custer, J., concur.*
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.6050 Saliva absorber. ( a ) *Identification.* A saliva absorber is a device made of paper or cotton intended to absorb moisture from the oral cavity during dental procedures.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9. If the device is not labeled or otherwise represented as sterile, it is exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[52 FR 30097, Aug. 12, 1987, as amended at 54 FR 13830, Apr. 5, 1989; 66 FR 38799, July 25, 2001]
Calendar No. 141

103D CONGRESS

1ST SESSION S. J. RES. 78

[Report No. 103–96]

JOINT RESOLUTION

Designating the beach at 53 degrees 53′51′′N, 166

degrees 34′15′′W to 53 degrees 53′48′′N, 166 degrees 34′21′′W on Hog Island, which lies in theon June 3 and 4, 1942.the Japanese attack on Dutch Harbor, Unalaskament of the National Guard, who served duringsas Beach’’ in commemoration of the 206th regiNortheast Bay of Unalaska, Alaska as ‘‘ArkanJULY 16 (legislative day, JUNE 30), 1993

Reported without amendment
II

Calendar No. 141

103D CONGRESS

1ST SESSION S. J. RES. 78

[Report No. 103–96]

Designating the beach at 53 degrees 53′51′′N, 166 degrees 34′15′′W to

53 degrees 53′48′′N, 166 degrees 34′21′′W on Hog Island, which lies

in the Northeast Bay of Unalaska, Alaska as ‘‘Arkansas Beach’’ in

commemoration of the 206th regiment of the National Guard, who served

during the Japanese attack on Dutch Harbor, Unalaska on June 3

and 4, 1942.

IN THE SENATE OF THE UNITED STATES

MARCH 31 (legislative day, MARCH 3), 1993

Mr. MURKOWSKI (for himself, Mr. PRYOR, Mr. BUMPERS, and Mr. STEVENS)

introduced the following joint resolution; which was read twice and referred to the Committee on Energy and Natural Resources

JULY 16 (legislative day, JUNE 30), 1993

Reported by Mr. JOHNSTON, without amendment

JOINT RESOLUTION

Designating the beach at 53 degrees 53′51′′N, 166 degrees

34′15′′W to 53 degrees 53′48′′N, 166 degrees 34′21′′W

on Hog Island, which lies in the Northeast Bay of Unalaska, Alaska as ‘‘Arkansas Beach’’ in commemoration

of the 206th regiment of the National Guard, who served

during the Japanese attack on Dutch Harbor, Unalaska

on June 3 and 4, 1942.
2

•SJ 78 RS

Whereas it is commonly overlooked that the Aleutian Islands

are the only part of American territory in history to be

invaded and overtaken by an enemy;

Whereas, during World War II, an Arkansas National Guard

Regiment, the 206th Coast Artillery, served diligently

and bravely on Hog Island, Unalaska;

Whereas the 206th Coast Artillery Regiment of Arkansas was

guarding Dutch Harbor during the time of the Japanese

attack;

Whereas, during the Japanese invasion of Dutch Harbor,

three young soldiers of the 206th Coast Artillery Unit

were killed;

Whereas the city of Unalaska, Alaska has passed Res. 92–

28, designating the beach at 53 degrees 53′51′′N, 166

degrees 34′15′′W to 53 degrees 53′48′′N, 166 degrees

34′21′′W on Hog Island, Unalaska as ‘‘Arkansas Beach’’;

and

Whereas the State of Alaska has passed Sen. Con. Res. 37,

as sent to the State Geographic Board, which names this

beach ‘‘Arkansas Beach’’: Now, therefore, be it

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled,

3 That the the beach at 53 degrees 53′51′′N, 166 degrees

4 34′15′′W to 53 degrees 53′48′′N, 166 degrees 34′21′′W on

5 Hog Island, Unalaska be named ‘‘Arkansas Beach’’ in

6 commemoration of the 206th Coast Artillery Regiment

7 and the men who served and died during the air attacks

8 on Dutch Harbor, Unalaska on June 3 and 4, 1942.
Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2013 Stock Incentive Plan, the 2015 Stock Incentive Plan and the 2015 Employee Stock Purchase Plan of Editas Medicine, Inc. of our report dated March 29, 2016, with respect to the consolidated financial statements of Editas Medicine, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2015.

 

|   |                                |
|--------|-------------------------------------|
|   | /s/ Ernst & Young LLP |

 

Boston, MassachusettsMarch 29, 2016

 

----